Tyring SK - Search Results

1

Comparison of risankizumab and apremilast for the treatment of adults with moderate plaque psoriasis eligible for systemic therapy: results from a randomized, open-label, assessor-blinded phase IV study (IMMpulse).

Stein Gold LF, Bagel J, Tyring SK, Hong HC, Pavlovsky L, Vender R, Pinter A, Reich A, Drogaris L, Wu T, Patel M, Soliman AM, Photowala H, Stakias V, Richter S, Papp KA. Stein Gold LF, et al. Among authors: tyring sk. Br J Dermatol. 2023 Oct 25;189(5):540-552. doi: 10.1093/bjd/ljad252. Br J Dermatol. 2023. PMID: 37488811 Clinical Trial.

2

Improvements in acne and skin oiliness with tazarotene 0.045% lotion in patients with oily skin.

Tanghetti EA, Zeichner JA, Gold M, Sadick N, Cook-Bolden FE, Kircik LH, Stein Gold L, Weiss J, Tyring SK, Del Rosso JQ, Guenin E. Tanghetti EA, et al. Among authors: tyring sk. J Dermatolog Treat. 2023 Dec;34(1):2147391. doi: 10.1080/09546634.2022.2147391. J Dermatolog Treat. 2023. PMID: 36382987 Free article. Clinical Trial.

3

Psoriasis improvements and inflammatory biomarker normalization with secukinumab: the randomized ObePso-S study.

Blauvelt A, Pariser DM, Tyring S, Bagel J, Alexis AF, Soung J, Armstrong AW, Muscianisi E, Kianifard F, Steadman J, Sarkar RP, Garcet S, Krueger JG. Blauvelt A, et al. J Dermatol Sci. 2023 Jan;109(1):12-21. doi: 10.1016/j.jdermsci.2023.01.003. Epub 2023 Jan 9. J Dermatol Sci. 2023. PMID: 36690571 Free article. Clinical Trial.

4

Current treatments and emerging therapies of human polyomavirus-associated skin diseases: a comprehensive review.

Bartley BR, Moore SA, Doan HQ, Rady PL, Tyring SK. Bartley BR, et al. Among authors: tyring sk. Int J Dermatol. 2023 Mar;62(3):387-396. doi: 10.1111/ijd.16534. Epub 2022 Dec 28. Int J Dermatol. 2023. PMID: 36577746 Review.

5

Effect of selinexor on lipogenesis in virus-positive Merkel cell carcinoma cell lines.

Landes JR, Bartley BR, Moore SA, He Q, Simonette R, Rady PL, Doan HQ, Tyring SK. Landes JR, et al. Among authors: tyring sk. Clin Exp Dermatol. 2023 Jul 21;48(8):903-908. doi: 10.1093/ced/llad081. Clin Exp Dermatol. 2023. PMID: 37191210

6

Efficacy and safety of vixarelimab, a human monoclonal oncostatin M receptor β antibody, in moderate-to-severe prurigo nodularis: a randomised, double-blind, placebo-controlled, phase 2a study.

Sofen H, Bissonnette R, Yosipovitch G, Silverberg JI, Tyring S, Loo WJ, Zook M, Lee M, Zou L, Jiang GL, Paolini JF. Sofen H, et al. EClinicalMedicine. 2023 Feb 3;57:101826. doi: 10.1016/j.eclinm.2023.101826. eCollection 2023 Mar. EClinicalMedicine. 2023. PMID: 36816342 Free PMC article.

7

Herpes manuum: a new name for non-digit herpetic whitlow.

Miller AC, Jr AS, Adjei S, Temiz LA, Tyring SK. Miller AC, et al. Among authors: tyring sk. Dermatol Online J. 2022 Oct 15;28(5). doi: 10.5070/D328559242. Dermatol Online J. 2022. PMID: 36809130

8

Novel use of dupilumab in pemphigus vulgaris and pemphigus foliaceus.

Jiang C, Adjei S, Santiago S, Lu J, Duran M, Tyring S. Jiang C, et al. JAAD Case Rep. 2023 Sep 30;42:12-15. doi: 10.1016/j.jdcr.2023.09.018. eCollection 2023 Dec. JAAD Case Rep. 2023. PMID: 37965194 Free PMC article. No abstract available.

9

Treatment of Kaposi sarcoma with intralesional cidofovir in an HIV-negative man.

Fenner B, Burningham K, Alkul M, Tyring S. Fenner B, et al. JAAD Case Rep. 2023 Oct 15;42:47-48. doi: 10.1016/j.jdcr.2023.09.036. eCollection 2023 Dec. JAAD Case Rep. 2023. PMID: 38034368 Free PMC article. No abstract available.

10

Antibiotic Resistance in Dermatology Part 1: Mechanisms of Resistance.

Miller AC, Adjei S, Temiz LA, Tyring SK. Miller AC, et al. Among authors: tyring sk. Skin Therapy Lett. 2023 Jan;28(1):7-10. Skin Therapy Lett. 2023. PMID: 36657435 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

675 results

Search Page